Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer.
Clin Colorectal Cancer. 2011 Jun;10(2):117-20. doi: 10.1016/j.clcc.2011.03.008. Epub 2011 Apr 28.
Clin Colorectal Cancer. 2011.
PMID: 21859564
Clinical Trial.
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
Carneiro BA, Ramanathan RK, Fakih MG, Krishnamurthi SS, Lembersky BC, Stoller RG, Lancaster SL, Pinkerton RA, Crandall TL, Schmotzer AR, Potter DM, Bahary N.
Carneiro BA, et al. Among authors: pinkerton ra.
Clin Colorectal Cancer. 2012 Mar;11(1):53-9. doi: 10.1016/j.clcc.2011.05.003. Epub 2011 Aug 2.
Clin Colorectal Cancer. 2012.
PMID: 21813336
Clinical Trial.
Item in Clipboard
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer.
Matin K, Jacobs SA, Richards T, Wong MK, Earle M, Evans T, Troetschel M, Ferri W, Friedland D, Pinkerton R, Volkin R, Wieand S, Ramanathan RK.
Matin K, et al.
Am J Clin Oncol. 2005 Oct;28(5):439-44. doi: 10.1097/01.coc.0000170797.36351.3a.
Am J Clin Oncol. 2005.
PMID: 16199980
Clinical Trial.
Item in Clipboard
Cite
Cite